Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a german multicenter trial

Gastrointestinal stromal tumors (GIST) are mesenchymal tumors that in the past were classified as leiomyosarcomas or leiomyomas not responding to standard sarcoma chemotherapy. In several phase I and II trials the efficacy and safety of imatinib was shown before the largest trial ever performed in a...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Schlemmer, M, Bauer, S, Schütte, R, Hartmann, JT, Bokemeyer, C, Hosius, C, Reichardt, P
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2011
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3352192/
https://ncbi.nlm.nih.gov/pubmed/21719393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-783X-16-5-206
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы